GlassScriptPhysician profile
Curtis A Bush
NPI 1881829737
$14,915.79
in general payments reported to CMS, 2019-2025
30 companies · $1,011 in 2025
The $1,011 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,507 · 2020: $2,441 · 2021: $3,417 · 2022: $2,874 · 2023: $1,589 · 2024: $2,077 · 2025: $1,011.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,439 · Travel and Lodging: $1,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,439.06 |
| Travel and Lodging | $1,238.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $7,338.72 | 2019-2025 | |
| Arthrex, INC. | $2,734.68 | 2019-2024 | |
| Stryker Corporation | $947.53 | 2019-2025 | Blueprint Patient Specific Instrumentation, Iconix, Augment Injectable |
| International Life Sciences | $891.97 | 2023 | |
| Encore Medical, LP | $570.79 | 2021-2025 | Djo Surgical |
| Smith+Nephew, INC. | $501.78 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Trigen Intertan, Evos |
| Zimmer Biomet Holdings, INC. | $286.66 | 2019-2024 | Identity, Rosa, Tapestry |
| Ferring Pharmaceuticals INC. | $233.57 | 2019-2025 | Euflexxa |
| Vericel Corporation | $193.61 | 2025 | Maci |
| Bioventus LLC | $126.11 | 2021-2025 | Exogen Ultrasound Bone Healing System, L360 Thigh System |
| Depuy Synthes Sales INC. | $108.16 | 2019-2024 | Monovisc, Healix Knotless Peek, Truespan Orthocord |
| Orthofix Medical, INC. | $103.01 | 2019-2025 | Physio-Stim, Spinal-Stim |
| Vertex Pharmaceuticals Incorporated | $98.65 | 2025 | |
| Globus Medical, INC. | $97.77 | 2023 | Distal Tibia Plating, Proximal Humerus Strut |
| Pacira Therapeutics, INC. | $95.30 | 2019-2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $87.84 | 2022-2025 | Exparel, Zilretta, Iovera |
| Trimed, INC. | $83.51 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $70.99 | 2023-2025 | Caldolor |
| Highridge Medical LLC | $52.50 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Davol INC. | $38.55 | 2023 | |
| Lima USA, INC. | $36.64 | 2019 | |
| Medtronic, INC. | $35.37 | 2023 | Cd Horizon Spinal System |
| Electronic Waveform Lab, INC. | $35.20 | 2025 | |
| Flower Orthopedics Coporation | $29.77 | 2024 | |
| Innovation Technologies INC | $24.30 | 2024 | Irrisept |
| Baxter Healthcare | $23.59 | 2023 | Floseal |
| Kerecis Limited | $20.46 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Treace Medical Concepts, INC. | $18.80 | 2024 | |
| Nevro Corp. | $15.89 | 2021 | |
| Convatec INC. | $14.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Curtis Bush listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.